Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;97(1):22-29.
doi: 10.1002/ccd.28715. Epub 2020 Jan 8.

Management of stent underexpansion using intravascular lithotripsy-Defining the utility of a novel device

Julian Yeoh  1 , Daan Cottens  2 , Claudia Cosgrove  2 , Khaled Mallek  2 , Julian Strange  3 , Richard Anderson  4 , Simon Wilson  5 , Colm Hanratty  5 , Simon Walsh  5 , Margaret McEntegart  6 , Jonathan Hill  1 , James C Spratt  2
Affiliations

Management of stent underexpansion using intravascular lithotripsy-Defining the utility of a novel device

Julian Yeoh et al. Catheter Cardiovasc Interv. .

Abstract

Objectives: This study aimed to present a case series of patient treated for stent underexpansion resistant to conventional treatment with intravascular lithotripsy (IVL).

Background: Stent underexpansion is a powerful predictor of long-term stent patency and correlates with unfavorable clinical outcomes. This case series demonstrates the utility of IVL in managing stent underexpansion resistant to conventional treatment.

Methods: We describe a case series of patients with stent underexpansion due to calcific coronary artery disease treated with IVL. Stent underexpansion was identified as an inability to adequately expand stents with conventional treatment. Only cases that failed to achieve adequate expansion with high-pressure noncompliant balloon inflation were included.

Results: Thirteen patients from six institutions have been included in this case series. The average age was 70.25 years with 76.9% of male patients. The average pre-IVL minimal stent area (MSA) was 2.71 mm2 , which improved to 6.44 mm2 post-IVL treatment, representing an average MSA gain of 238%. There were no procedural, peri-procedural, or 30-day major adverse cardiac and cerebrovascular event.

Conclusion: This case series demonstrates that IVL is a feasible, safe alternative for the management of stent underexpansion due to calcific coronary disease.

Keywords: drug-eluting stents; intravascular lithotripsy; optical coherence tomography; percutaneous coronary intervention; stent failure.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Kang SJ, Mintz GS, Park DW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis. Circ Cardiovasc Interv. 2011;4:9-14.
    1. Fitzgerald PJ, Oshima A, Hayase M, et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000;102:523-530.
    1. Kaneda H, Ma J, Morita T. Stent underexpansion in early drug-eluting stent thrombosis. JACC Cardiovasc Interv. 2009;2:807.
    1. Kobayashi Y, Okura H, Kume T, et al. Impact of target lesion coronary calcification on stent expansion. Circ J. 2014;78:2209-2214.
    1. Kim JS, Moon JY, Ko YG, et al. Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]). Am J Cardiol. 2008;102:304-310.

LinkOut - more resources